Clinical Trials in San Antonio

Showing 2941-2960 of 7,028 trials

Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM

NCT02981069

In this study, the researchers hope to learn about SGLT2 inhibition on EGP (endogenous glucose production) and plasma glucose concentration in diabetic subjects. Researchers will examine diabetes and the role of increased plasma glucagon, decline in plasma insulin, and fall in plasma glucose concentration.

Diabetes Mellitus, Type 2

The University of Texas Health Science Center at San Antonio90 participantsStarted Dec 2017

San Antonio, Texas, United States

COMPLETEDNA< 1 mile

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

NCT04769596

A randomized, sham-controlled, double-blind study of the NEUROMARKTM system as a treatment for chronic rhinitis

Chronic Rhinitis

Neurent Medical143 participantsStarted Feb 2021

Birmingham, Alabama, United States • Roseville, California, United States • Colorado Springs, Colorado, United States +5 more locations

COMPLETEDPhase 1< 1 mile

A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

NCT05517525

The primary purpose of the study is to compare the PK of a single dose of brensocatib in participants with hepatic impairment to that in matched healthy control participants with normal hepatic function.

Hepatic Impairment

Insmed Incorporated30 participantsStarted Oct 2022

Rialto, California, United States • Orlando, Florida, United States • San Antonio, Texas, United States

Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Find Trials by Condition in San Antonio

Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors

Couple's Retreats for Posttraumatic Stress Disorder

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)

Bucillamine in Treatment of Patients With COVID-19

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)

PDGeneration: Mapping the Future of Parkinson's Disease

Simple Bone Cysts in Kids

A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma

Relapse Prevention Study in Patients With Schizophrenia

Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

A Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Participants With Cystic Fibrosis (CF)